2Mieltinen M, Lasota J. ftistopathology of gastrointestinal stromal tumor[J]. J SurgOncol, 2011,104(8) :864 -73.
3Feng Y, Hu J, Ma J, et al. RNAi-medialed silencing of VEGF-C inhibits non-small cell lung cancer progression by simuhaneously down-regulating tile CXCR4, CCR7, VEGFR-2 and VEGFR-3-de- pendent axes-induced EttK, p38 and AKT signalling pathways [J]. EurJCancer, 2011,47(15) :2353 -63.
4Hanhan D, Weinherg R A. Hallmarks of cancer: the next genera- tion[J]. Cell, 2011,144(5):646-74.
5Tallant C, MmTero A, Gomis-Ruth F X. Matrix metalloproteinas- es:fold and function of their catalytic domains[ J]. Biochim Bio- phys Acta, 2010,1803 ( 1 ) :20 - 8.
6Amalinei C, Caruntu I D, Giusca S E, et al. Matrix metalloprotei- nasesinvolvenent in pathological Enb3ol, 2010,51 (2) :215 -28.
7Andreas G N, Heinz L, Gerd M, et al. Double-blind, p[acebo- eontrolled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in pa- tients with stage IV and locally advanced pancreatic cancer [ J ]. BMC Cancer, 2012,12:361.
8Takahashi R, tanaka S, Kitadai Y, et al. Expression of vascular endothelial growth fatbor and angiogenesis in gastrointestinal stro- real tumor of the stomach [ J ]. Oncology, 2003,64 ( 3 ) :266 - 74.
